Focus: Magnus Medical is a public-stage medical device company headquartered in Burlingame, CA, specializing in neuromodulation systems for psychiatric and neurological disorders, particularly depression treatment.
Profile data last refreshed 57m ago · AI intelligence enriched 2mo ago
Suitable for specialists in neuromodulation or psychiatric devices seeking early-stage device innovation, but limited near-term career growth visibility due to constrained hiring.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Magnus Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Magnus Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Clinical and functional connectivity changes following the stanford accelerated intelligent neuromodulation therapy (SAINT) in bipolar I depression: A pilot study.
Real-world evidence of SAINT® effectiveness in a heterogenous clinical population with psychiatric and medical comorbidities: A multicenter, open-label, community-based study.
Showing 5 of 7 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo